CSPG4 and oligodendroglioma: After stratification for the histologic grade, grade III oligodendrogliomas, expressing either diffuse or focal NG2/CSPG4 immunoreactivity, showed the worst prognosis (p > 0.05, log-rank test) (data not shown).